CLINICAL TRIALS PROFILE FOR LOTREL
✉ Email this page to a colleague
All Clinical Trials for LOTREL
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00234871 ↗ | Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM) | Completed | Abbott | Phase 4 | 2004-01-01 | The primary objective of this study is to determine if trandolapril/verapamil (Tarka®) is superior to amlodipine/benazepril (Lotrel®) in reduction of albuminuria in hypertensive subjects with Type 2 diabetes mellitus (DM) and diabetic nephropathy |
| NCT00649402 ↗ | Fed Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mg | Completed | Mylan Pharmaceuticals | Phase 1 | 2004-05-01 | The objective of this study was to investigate the bioequivalence of Mylan amlodipine and benazepril HCl 10 mg/20 mg to Novartis Lotrel® 10 mg/20 mg combination capsules following a single, oral 10 mg/20 mg (1 x 10 mg/20 mg) dose administered under fed conditions. |
| NCT00649519 ↗ | Fasting Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mg | Completed | Mylan Pharmaceuticals | Phase 1 | 2004-05-01 | The objective of this study was to investigate the bioequivalence of Mylan's amlodipine and benazepril HCl 10 mg/20 mg to Novartis' Lotrel® 10 mg/20 mg combination capsules following a single, oral 10 mg/20 mg (1 x 10mg/20mg) dose administered under fasting conditions. |
| NCT00834977 ↗ | Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fasting Conditions | Completed | Teva Pharmaceuticals USA | Phase 1 | 2004-04-01 | The objective of this study is to compare the rate and extent of absorption of amlodipine-benzazepril 10 mg-20 mg capsules (test) versus Lotrel® (reference), administered as 1 x 10 mg capsule under fasting conditions. |
| NCT00835367 ↗ | Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fed Conditions | Completed | Teva Pharmaceuticals USA | Phase 1 | 2004-03-01 | The objective of this study is to compare the rate and extent of absorption if amlodipine-benzazepril 10 mg-20 mg capsules (test) versus Lotrel® (reference),administered as 1 x 10 mg- 20 mg capsule under fed conditions. |
| NCT01155895 ↗ | Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Fasting Conditions | Completed | Dr. Reddy's Laboratories Limited | Phase 1 | 2004-03-01 | The objective of this study was to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Lotrel®) 10 mg amlodipine besylate/20 mg benazepril hydrochloride capsules, under fasting conditions. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for LOTREL
Condition Name
Clinical Trial Locations for LOTREL
Trials by Country
Clinical Trial Progress for LOTREL
Clinical Trial Phase
Clinical Trial Sponsors for LOTREL
Sponsor Name
